1305-0031
This study is open to people with idiopathic pulmonary fibrosis (IPF) or progressive pulmonary fibrosis (PPF). They can only take part if they have completed treatment in a previous study with a medicine called nerandomilast or BI 1015550 (study�
- Investigator
- Christopher Harden
- Status
- Accepting Candidates
- Ages
- 18 Years - N/A
- Sexes
- All
A Study to Evaluate the Efficacy, Safety, and Tolerability of BMS-986278 in Participants with IPF
The purpose of this study is to evaluate the efficacy, safety, and tolerability of BMS-986278 in Participants with Progressive Pulmonary Fibrosis.
- Investigator
- Christopher Harden
- Status
- Accepting Candidates
- Ages
- 21 Years - N/A
- Sexes
- All
ALOFT-PPF
The purpose of this study is to evaluate the efficacy, safety, and tolerability of BMS-986278 in Participants with Progressive Pulmonary Fibrosis.
- Investigator
- Christopher Harden
- Status
- Accepting Candidates
- Ages
- 21 Years - N/A
- Sexes
- All